pubmed-article:11828293 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C0038160 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C0007546 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C0042313 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C0542559 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C1955827 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C0524727 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:11828293 | lifeskim:mentions | umls-concept:C1512456 | lld:lifeskim |
pubmed-article:11828293 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11828293 | pubmed:dateCreated | 2002-2-5 | lld:pubmed |
pubmed-article:11828293 | pubmed:abstractText | This study was undertaken to compare the efficacy of vancomycin prophylaxis with that of cefazolin in preventing surgical site infections in a tertiary medical center with a high prevalence of methicillin-resistant staphylococcal infections. | lld:pubmed |
pubmed-article:11828293 | pubmed:language | eng | lld:pubmed |
pubmed-article:11828293 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11828293 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:11828293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11828293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11828293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11828293 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11828293 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11828293 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11828293 | pubmed:issn | 0022-5223 | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:MashiahTT | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:FinkelsteinRR | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:MiloSS | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:CohenOO | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:RabinoGG | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:Bar-ElYY | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:AdlerZZ | lld:pubmed |
pubmed-article:11828293 | pubmed:author | pubmed-author:KertzmanVV | lld:pubmed |
pubmed-article:11828293 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11828293 | pubmed:volume | 123 | lld:pubmed |
pubmed-article:11828293 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11828293 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11828293 | pubmed:pagination | 326-32 | lld:pubmed |
pubmed-article:11828293 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:meshHeading | pubmed-meshheading:11828293... | lld:pubmed |
pubmed-article:11828293 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11828293 | pubmed:articleTitle | Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. | lld:pubmed |
pubmed-article:11828293 | pubmed:affiliation | Rambam Medical Center, Haifa, Israel. rfinkelstein@rambam.health.gov.il | lld:pubmed |
pubmed-article:11828293 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11828293 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11828293 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11828293 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11828293 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11828293 | lld:pubmed |